Josh Gottheimer sold Vertex Pharmaceuticals Inc (NASDAQ: VRTX)
Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 6 trades in Vertex Pharmaceuticals Inc (VRTX) since 2017, 2 purchases and 4 sales, worth an estimated $48K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Josh Gottheimer sold $1,001 - $15,000 of Vertex Pharmaceuticals Inc (NASDAQ: VRTX) on April 11, 2019. Since that trade, VRTX is up +161.09% against the S&P 500 up +180.97%, an outperformance of -19.88%.
Across these filings, Josh Gottheimer has been a net seller of VRTX (a buy-to-sell ratio of 0.50). The most recent disclosed VRTX transaction shown was dated September 19, 2019. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Josh Gottheimer's VRTX trades vs the price
VRTX is up +161.09% since Josh Gottheimer sold on April 11, 2019, versus +180.97% for the S&P 500.
Performance since this trade
All Josh Gottheimer VRTX trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Josh Gottheimer & VRTX trading FAQ
Is it legal for Josh Gottheimer to trade Vertex Pharmaceuticals Inc (VRTX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Vertex Pharmaceuticals Inc (VRTX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Josh Gottheimer sell VRTX?
Josh Gottheimer disclosed a sale of $1,001 - $15,000 of Vertex Pharmaceuticals Inc (VRTX) on April 11, 2019, according to public STOCK Act filings.
How has VRTX performed since Josh Gottheimer's trade?
Since Josh Gottheimer sold VRTX on April 11, 2019, the stock is up +161.09%, versus +180.97% for the S&P 500 over the same period, an outperformance of -19.88%.
How many times has Josh Gottheimer traded VRTX?
Josh Gottheimer has disclosed 6 VRTX trades since 2017 (2 purchases and 4 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional VRTX trades?
Quantellect tracks every disclosed congressional trade in Vertex Pharmaceuticals Inc (VRTX) on the Vertex Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Josh Gottheimer's VRTX tradesAll congressional filings for Vertex Pharmaceuticals IncJosh Gottheimer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.